[1]
R Mohamad Javier et al. 2023. Risk Factors of Patients with Gangrene Pedis with Type 2 Diabetes Mellitus Followed by Anti-Diabetic and Insulin Drug Therapy. Journal of Population Therapeutics and Clinical Pharmacology. 30, 13 (Jun. 2023), 108–117. DOI:https://doi.org/10.47750/jptcp.2023.30.13.010.